Thyroid stimulating hormone (TSH) suppression is not associated with better outcomes in intermediate and high risk thyroid cancer patients
Institution: MedStar Washington Hospital CenterDepartment: Medicine/Endocrinology | Medicine/Nuclear MedicineForm of publication: ConferenceYear: 2016Conference information: Conference presentation at: Endocrine Society Annual Meeting 2016, Boston, MA, 2016/04/01Fiscal year: FY2016Local accession number: 2016_240Date added to catalog: 2017-05-06| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Conference | MedStar Authors Catalog | Conference | Available |